R. Dyall et al., Cellular requirements for the monoclonal antibody-mediated eradication of an established solid tumor, EUR J IMMUN, 29(1), 1999, pp. 30-37
Following subcutaneous implantation, the murine lymphoma E.G7 [a variant of
EL-4, transfected with the chicken ovalbumin (OVA) gene] up-regulates the
CD4 molecule. We previously showed that the administration of an anti-CD4 m
onoclonal antibody (mAb) to EG.7-bearing mice leads to a rapid and complete
regression of large established tumors. This tumor regression was shown to
require both CD8(+) cells and functional Fc gamma receptors (Fc gamma R),
as it failed to occur in mice depleted of CD8 cells, or mice genetically de
ficient in Fc gamma RI/III (gamma(-/-) mice). Using adoptive transfer, we n
ow show that the Fc gamma R+ cells required for this regression are the CD1
1b(+) (phagocytic) cells. Furthermore, experiments using peptide tolerizati
on demonstrated that the critical CD8 CTL population in this model is tumor
specific. Analysis of tumors at various stages of regression revealed a ma
ssive CD11b(+) Fc gamma R+ and a marginal CD8 infiltration. In the presence
of the CTL determinant OVA-8 on tumor cells and of the antitumor mAb, this
CD8 infiltration became remarkable, and correlated with tumor regression.
These results identify the specific cellular effecters essential for the mA
b-mediated tumor regression, and suggest that Fc gamma R-activated macropha
ges induced an expansion of tumor-eliminating CTL in situ.